Earnings Summary

VBI Vaccines Inc’s revenue fell -31.98% since last year same period to $0.23Mn in the Q2 2018. On a quarterly growth basis, VBI Vaccines Inc has generated 31.46% jump in its revenue since last 3-months.

VBI Vaccines Inc’s net profit fell -85.63% since last year same period to $-16.73Mn in the Q2 2018. On a quarterly growth basis, VBI Vaccines Inc has generated -36.57% fall in its net profits since last 3-months.

VBI Vaccines Inc’s net profit margin fell -172.89% since last year same period to -7150% in the Q2 2018. On a quarterly growth basis, VBI Vaccines Inc has generated -3.89% fall in its net profit margins since last 3-months.

VBI Vaccines Inc’s earning per share (EPS) estimates for the current quarter stand at -0.06 - a 25% jump from last quarter’s estimates.

VBI Vaccines Inc’s earning per share (EPS) estimates for the current year stand at -0.06.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. VBI Vaccines Inc’s return on assets (ROA) stands at -0.28.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. VBI Vaccines Inc’s return on equity (ROE) stands at -1.09.